Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

ColoSeal™ ICD System Anastomotic Protection Pivotal Study

NCT: NCT07429110 · RECRUITING

NCT IDNCT07429110
StatusRECRUITING
Start Date2026-06-19
Completion2028-12
SponsorAverto Medical, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this clinical investigation is to evaluate the safety of the ColoSeal ICD System by evaluating its effectiveness in reducing the stoma creation rate and by comparing the rate of major complications to current standard of care for rectal cancer surgery with a diverting ostomy.

Frequently Asked Questions

What is ColoSeal™ ICD System Anastomotic Protection Pivotal Study?

ColoSeal™ ICD System Anastomotic Protection Pivotal Study is a clinical trial registered under NCT07429110. Current status: RECRUITING.

What is the status of NCT07429110?

The current status of NCT07429110 (ColoSeal™ ICD System Anastomotic Protection Pivotal Study) is: RECRUITING.

When did ColoSeal™ ICD System Anastomotic Protection Pivotal Study start?

ColoSeal™ ICD System Anastomotic Protection Pivotal Study started on 2026-06-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑